Literature DB >> 23969937

The G-protein-coupled receptor CLR is upregulated in an autocrine loop with adrenomedullin in clear cell renal cell carcinoma and associated with poor prognosis.

Leonid L Nikitenko1, Russell Leek, Stephen Henderson, Nischalan Pillay, Helen Turley, Daniele Generali, Sarah Gunningham, Helen R Morrin, Andrea Pellagatti, Margaret C P Rees, Adrian L Harris, Stephen B Fox.   

Abstract

PURPOSE: The G-protein-coupled receptor (GPCR) calcitonin receptor-like receptor (CLR) and its ligand peptide adrenomedullin (encoded by ADM gene) are implicated in tumor angiogenesis in mouse models but poorly defined in human cancers. We therefore investigated the diagnostic/prognostic use for CLR in human tumor types that may rely on adrenomedullin signaling and in clear cell renal cell carcinoma (RCC), a highly vascular tumor, in particular. EXPERIMENTAL
DESIGN: In silico gene expression mRNA profiling microarray study (n = 168 tumors) and cancer profiling cDNA array hybridization (n = 241 pairs of patient-matched tumor/normal tissue samples) were carried out to analyze ADM mRNA expression in 13 tumor types. Immunohistochemistry on tissue microarrays containing patient-matched renal tumor/normal tissues (n = 87 pairs) was conducted to study CLR expression and its association with clinicopathologic parameters and disease outcome.
RESULTS: ADM expression was significantly upregulated only in RCC and endometrial adenocarcinoma compared with normal tissue counterparts (P < 0.01). CLR was localized in tumor cells and vessels in RCC and upregulated as compared with patient-matched normal control kidney (P < 0.001). Higher CLR expression was found in advanced stages (P < 0.05), correlated with high tumor grade (P < 0.01) and conferred shorter overall survival (P < 0.01).
CONCLUSIONS: In human tissues ADM expression is upregulated in cancer type-specific manner, implicating potential role for adrenomedullin signaling in particular in RCC, where CLR localization suggests autocrine/paracrine mode for adrenomedullin action within the tumor microenvironment. Our findings reveal previously unrecognized CLR upregulation in an autocrine loop with adrenomedullin in RCC with potential application for this GPCR as a target for future functional studies and drug development. ©2013 AACR.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23969937      PMCID: PMC3836221          DOI: 10.1158/1078-0432.CCR-13-1712

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  47 in total

1.  affy--analysis of Affymetrix GeneChip data at the probe level.

Authors:  Laurent Gautier; Leslie Cope; Benjamin M Bolstad; Rafael A Irizarry
Journal:  Bioinformatics       Date:  2004-02-12       Impact factor: 6.937

Review 2.  Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference.

Authors:  Michael B Atkins; Marc S Ernstoff; Robert A Figlin; Keith T Flaherty; Daniel J George; William G Kaelin; Eugene D Kwon; Towia A Libermann; W Marston Linehan; David F McDermott; Augusto C Ochoa; Allan J Pantuck; Brian I Rini; Mark A Rosen; Jeffrey A Sosman; Vikas P Sukhatme; Johannes W Vieweg; Christopher G Wood; Laura King
Journal:  Clin Cancer Res       Date:  2007-01-15       Impact factor: 12.531

Review 3.  ABC of urology. Urological malignancy--III: Renal and testicular carcinoma.

Authors:  C Dawson; H Whitfield
Journal:  BMJ       Date:  1996-05-04

Review 4.  Hypoxia--a key regulatory factor in tumour growth.

Authors:  Adrian L Harris
Journal:  Nat Rev Cancer       Date:  2002-01       Impact factor: 60.716

5.  [TNM classification of malignant tumors: the new 1987 edition].

Authors:  P Hermanek; O Scheibe; B Spiessl; G Wagner
Journal:  Radiobiol Radiother (Berl)       Date:  1987

Review 6.  Adrenomedullin, a multifunctional regulatory peptide.

Authors:  J P Hinson; S Kapas; D M Smith
Journal:  Endocr Rev       Date:  2000-04       Impact factor: 19.871

7.  Adrenomedullin induces lymphangiogenesis and ameliorates secondary lymphoedema.

Authors:  Donghao Jin; Kazuhiko Harada; Shunsuke Ohnishi; Kenich Yamahara; Kenji Kangawa; Noritoshi Nagaya
Journal:  Cardiovasc Res       Date:  2008-08-16       Impact factor: 10.787

8.  Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.

Authors:  K Kitamura; K Kangawa; M Kawamoto; Y Ichiki; S Nakamura; H Matsuo; T Eto
Journal:  Biochem Biophys Res Commun       Date:  1993-04-30       Impact factor: 3.575

9.  Prognostic significance of morphologic parameters in renal cell carcinoma.

Authors:  S A Fuhrman; L C Lasky; C Limas
Journal:  Am J Surg Pathol       Date:  1982-10       Impact factor: 6.394

Review 10.  Adrenomedullin and tumour angiogenesis.

Authors:  L L Nikitenko; S B Fox; S Kehoe; M C P Rees; R Bicknell
Journal:  Br J Cancer       Date:  2006-01-16       Impact factor: 7.640

View more
  10 in total

1.  Expression and clinical significance of focal adhesion kinase and adrenomedullin in epithelial ovarian cancer.

Authors:  Mingqun Li; L I Hong; Meimei Liao; Guanglin Guo
Journal:  Oncol Lett       Date:  2015-05-27       Impact factor: 2.967

Review 2.  Recent Advances on the Role of G Protein-Coupled Receptors in Hypoxia-Mediated Signaling.

Authors:  Rosamaria Lappano; Damiano Rigiracciolo; Paola De Marco; Silvia Avino; Anna Rita Cappello; Camillo Rosano; Marcello Maggiolini; Ernestina Marianna De Francesco
Journal:  AAPS J       Date:  2016-02-10       Impact factor: 4.009

3.  The neuropeptide receptor calcitonin receptor-like (CALCRL) is a potential therapeutic target in acute myeloid leukemia.

Authors:  Linus Angenendt; Eike Bormann; Tobias Herold; Christoph Schliemann; Caroline Pabst; Vijay Alla; Dennis Görlich; Leonie Braun; Kim Dohlich; Christian Schwöppe; Stefan K Bohlander; Maria Francisca Arteaga; Klaus Wethmar; Wolfgang Hartmann; Adrian Angenendt; Torsten Kessler; Rolf M Mesters; Matthias Stelljes; Maja Rothenberg-Thurley; Karsten Spiekermann; Josée Hébert; Guy Sauvageau; Peter J M Valk; Bob Löwenberg; Hubert Serve; Carsten Müller-Tidow; Georg Lenz; Bernhard J Wörmann; M Christina Sauerland; Wolfgang Hiddemann; Wolfgang E Berdel; Utz Krug; Klaus H Metzeler; Jan-Henrik Mikesch
Journal:  Leukemia       Date:  2019-06-10       Impact factor: 11.528

4.  Genetic evidence of a precisely tuned dysregulation in the hypoxia signaling pathway during oncogenesis.

Authors:  Sophie Couvé; Charline Ladroue; Elodie Laine; Karène Mahtouk; Justine Guégan; Sophie Gad; Hélène Le Jeune; Marion Le Gentil; Gregory Nuel; William Y Kim; Bernard Lecomte; Jean-Christophe Pagès; Christine Collin; Françoise Lasne; Patrick R Benusiglio; Brigitte Bressac-de Paillerets; Jean Feunteun; Vladimir Lazar; Anne-Paule Gimenez-Roqueplo; Nathalie M Mazure; Philippe Dessen; Luba Tchertanov; David R Mole; William Kaelin; Peter Ratcliffe; Stéphane Richard; Betty Gardie
Journal:  Cancer Res       Date:  2014-11-04       Impact factor: 12.701

Review 5.  Adrenomedullin and tumour microenvironment.

Authors:  Ignacio M Larráyoz; Sonia Martínez-Herrero; Josune García-Sanmartín; Laura Ochoa-Callejero; Alfredo Martínez
Journal:  J Transl Med       Date:  2014-12-05       Impact factor: 5.531

6.  MEF2 transcription factors are key regulators of sprouting angiogenesis.

Authors:  Natalia Sacilotto; Kira M Chouliaras; Leonid L Nikitenko; Yao Wei Lu; Martin Fritzsche; Marsha D Wallace; Svanhild Nornes; Fernando García-Moreno; Sophie Payne; Esther Bridges; Ke Liu; Daniel Biggs; Indrika Ratnayaka; Shane P Herbert; Zoltán Molnár; Adrian L Harris; Benjamin Davies; Gareth L Bond; George Bou-Gharios; John J Schwarz; Sarah De Val
Journal:  Genes Dev       Date:  2016-10-15       Impact factor: 11.361

7.  PAFR selectively mediates radioresistance and irradiation-induced autophagy suppression in prostate cancer cells.

Authors:  Bing Yao; Bingqian Liu; Lei Shi; Xiang Li; Chuanchuan Ren; Mingbo Cai; Wen Wang; Jianhua Li; Yongde Sun; Yudong Wu; Jianguo Wen
Journal:  Oncotarget       Date:  2017-02-21

8.  Adrenomedullin promotes the growth of pancreatic ductal adenocarcinoma through recruitment of myelomonocytic cells.

Authors:  Min Xu; Feifei Qi; Shaosen Zhang; Xuhui Ma; Shan Wang; Chunying Wang; Yan Fu; Yongzhang Luo
Journal:  Oncotarget       Date:  2016-08-23

9.  Novel methylated DNA markers accurately discriminate Lynch syndrome associated colorectal neoplasia.

Authors:  Veroushka Ballester; William R Taylor; Seth W Slettedahl; Douglas W Mahoney; Tracy C Yab; Frank A Sinicrope; Clement R Boland; Graham P Lidgard; Marcia R Cruz-Correa; Thomas C Smyrk; Lisa A Boardman; David A Ahlquist; John B Kisiel
Journal:  Epigenomics       Date:  2020-12-22       Impact factor: 4.778

10.  Perivascular Neuropilin-1 expression is an independent marker of improved survival in renal cell carcinoma.

Authors:  Eric Morin; Cecilia Lindskog; Martin Johansson; Lars Egevad; Per Sandström; Ulrika Harmenberg; Lena Claesson-Welsh; Elin Sjöberg
Journal:  J Pathol       Date:  2020-01-29       Impact factor: 7.996

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.